Co-Founder and Managing Director of Intrepid Investment Bankers LLC; Co-Head of Healthcare Group Adam has more than 19 years of investment banking experience in the middle market. He joined Intrepid as Vice President and Founding Principal in 2010, after nearly a decade of focusing on middle-market mergers and acquisitions at Barrington Associates and Wells Fargo Securities.
Adam has executed M&A and capital raising transactions involving private and public companies in a broad variety of industries, including healthcare, consumer products, tech-enabled business services and industrial manufacturing. Active in the autism services space, Adam advised Autism Spectrum Therapies in its sale to Learn Behavioral and spoke at the 2019 and 2020 Autism Investor Summits.
In addition, Adam is a Board Member of Association for Corporate Growth (ACG) Los Angeles Chapter, Founder of ACG LA Rising Stars Program and serves on the Board of Directors of JVS SoCal, a non-profit founded in 1931 that empowers individuals to achieve economic independence through sustainable employment. Adam graduated from Skidmore College with a B.A. in Business and Economics.
Drawing upon three decades as a psychologist, clinician, and consultant—as well as executive leadership skills attained as the Founder and CEO of Autism Spectrum Therapies (acquired by Learn It Systems) — Ronit has a uniquely multi-faceted understanding of the behavioral healthcare landscape and a passion for helping those interested in the field to better understand the pathway ahead.
As an advisor to investors, service providers, clinical organizations, and communities, she provides cutting-edge insights into the rapidly expanding field of behavioral healthcare, helping leaders and delivery teams understand current trends and best practices, navigate complex care intersections, think strategically about growth and quality assurance, design innovative solutions, and identify/pursue intelligent behavioral health investment opportunities.
Dr. Molko provides support to investors during diligence, deal negotiation and post-deal integration — in addition to advising them on how best to position portfolio companies for sustainable growth. She helps organizations develop breakthrough solutions and service lines aimed at addressing the complex needs of individuals, families, and communities dealing with autism and other developmental disorders, mental health issues, brain trauma, home health and age-related memory loss.
In her highly-lauded book, Autism Matters: Empowering Investors, Providers and the Autism Community to Advance Autism Services, Dr. Molko takes a critical look at where the autism market is today and how it needs to progress to meet the growing needs of its consumers. She is a Forbes contributor and her talk: “Reconsidering the Autism Spectrum” is featured on TED.com.
Dr. Ronit’s educational credentials include a PhD in Applied Behavioral Science & Family Life from the University of Kansas; an M.S. in Psychology from Claremont Graduate University; and a B.A. in Psychology from American Jewish University. Additionally, she is a graduate of Harvard's three-year OPM (Owner/President Management) executive leadership program — as well as a Licensed Clinical Psychologist (CA & WA) and Board-Certified Behavior Analyst (BCBA-D).
Dan is a successful entrepreneur, master convener, and father of a 26-year-old son with autism. He advises and mentors autism companies, assisting them with high-level strategy, funding, and pilot sites. This work is the genesis of BlueUmbrella, which promises to radically expand this assistance to hundreds of companies. Concurrent with founding BlueUmbrella, Dan has played a key role on the organizing team in launching the Autism Impact Fund, which, with a goal of $100M, is on track to be the largest social impact fund in this arena.